Skip to main content

Monroe Christopher's Form 4/A amendment

Amended

IonQ, Inc. (IONQ) · filed Jun 6, 2023

Accession no.
0001209191-23-034921
Filed
Jun 6, 2023
Trade date
Jun 1, 2023
Filing delay
5 days
Rule 10b5-1 plan
Not checked
Original filed
Jun 5, 2023

This filing lists 1 non-derivative transaction. It carries over 1 transaction from the original filing that it did not restate. Open-market sales total $2.18M. It was filed 5 days after the trade.

This amendment restates part of 0001209191-23-034487 (filed Jun 5, 2023). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Monroe ChristopherCIK 0001885206Officer (Chief Scientist)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 1, 2023Common StockSSaleDisposed−200,000$10.75F1−$2,150,0003,856,254Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001209191-23-034487 (filed Jun 5, 2023).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001209191-23-034487
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 25, 2023Common StockSSaleDisposed−2,680$10.52−$28,193.64,056,254Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.67 to $10.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F2

The initial Form 4 inadvertently listed the incorrect number of shares beneficially owned after the transaction.

Read the full filing on SEC EDGAR (opens in a new tab)